Completed An Extension Study to Assess the Long-term Safety and Efficacy of Hunterase (Idursulfase Beta) NCT07344376 Conditions Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +27 more Locations Samsung Medical Center — Seoul, South Korea View Trial Details
